19
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELTROMBOPAG OLAMINE, with a corresponding application number 207027.
Regulatory Information RX
With a dosage strength EQ 12.5MG ACID/PACKET
Dosage Form Route FOR SUSPENSION; ORAL
Reference Listed Drug Yes
Approved since 2018-09-27
18
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELTROMBOPAG OLAMINE, with a corresponding application number 207027.
Regulatory Information RX
With a dosage strength EQ 25MG ACID/PACKET
Dosage Form Route FOR SUSPENSION; ORAL
Reference Listed Drug Yes
Approved since 2015-08-24